Lessons from the COVID-19 pandemic and recent developments on the communication of clinical trials, publishing practices, and research integrity: in conversation …

DO Lawson, MK Wang, K Kim, R Eikelboom… - Trials, 2022 - Springer
Background The torrent of research during the coronavirus (COVID-19) pandemic has
exposed the persistent challenges with reporting trials, open science practices, and …

Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement

Y Yin, F Shi, Y Zhang, X Zhang, J Ye, J Zhang - PLoS One, 2021 - journals.plos.org
Objective To evaluate the reporting quality of randomized controlled trials (RCTs) regarding
patients with COVID-19 and analyse the influence factors. Methods PubMed, Embase, Web …

Reporting clinical studies affected by the COVID-19 pandemic: guidelines for authors

RH Perlis, SJPA Haneuse, GD Rubenfeld… - JAMA network …, 2021 - jamanetwork.com
The coronavirus disease 2019 (COVID-19) pandemic has affected every area of society, and
clinical investigation is no exception. 1 The unprecedented speed and volume of scientific …

Transparency and reporting characteristics of COVID-19 randomized controlled trials

P Kapp, L Esmail, L Ghosn, P Ravaud, I Boutron - BMC medicine, 2022 - Springer
Background In the context of the COVID-19 pandemic, randomized controlled trials (RCTs)
are essential to support clinical decision-making. We aimed (1) to assess and compare the …

Poor reporting quality of randomized controlled trials comparing treatments of COVID-19–A retrospective cross-sectional study on the first year of publications

L Gruesser, C Eissing, A Kowark, AP Keszei… - Plos one, 2023 - journals.plos.org
Introduction Transparent and complete reporting of randomized controlled trials (RCTs) is
essential for critical scientific appraisal of the results. It has been argued whether …

Research integrity during the COVID-19 pandemic: Perspectives of health science researchers at an Academic Health Science Center

EMR Smith, C Rakestraw, JS Farroni - Accountability in Research, 2023 - Taylor & Francis
During the coronavirus disease 2019 pandemic, a complex mix of political pressure, social
urgency, public panic, and scientific curiosity has significantly impacted the context of …

Following the science? Comparison of methodological and reporting quality of covid-19 and other research from the first wave of the pandemic

TJ Quinn, JK Burton, B Carter, N Cooper, K Dwan… - BMC medicine, 2021 - Springer
Background Following the initial identification of the 2019 coronavirus disease (covid-19),
the subsequent months saw substantial increases in published biomedical research …

Completeness and spin of medRxiv preprint and associated published abstracts of COVID-19 randomized clinical trials

H Spungen, J Burton, S Schenkel, DL Schriger - JAMA, 2023 - jamanetwork.com
Methods| We identified all COVID-19–related RCT preprints posted to medRxiv between
January 1, 2020, and December 31, 2021. On June 1, 2022, and November 15, 2022, title …

Reporting transparency: making the ethical mandate explicit

SG Nicholls, SM Langan, EI Benchimol, D Moher - BMC medicine, 2016 - Springer
Improving the transparency and quality of reporting in biomedical research is considered
ethically important; yet, this is often based on practical reasons such as the facilitation of …

Building an infrastructure to support the development, conduct, and reporting of informative clinical studies: The Rockefeller University experience

RG Kost, RK Devine, M Fernands… - Journal of Clinical and …, 2023 - cambridge.org
Introduction: Clinical trials are a vital component of translational science, providing crucial
information on the efficacy and safety of new interventions and forming the basis for …